V. Lejour

发表

Fuzzy Tandem Repeats Containing p53 Response Elements May Define Species-Specific p53 Target Genes

F. Toledo, I. Simeonova, V. Lejour, 2012, PLoS genetics.

Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity

A. Jochemsen, F. Toledo, I. Simeonova, 2014, Oncogene.

Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance

S. Savage, Eléonore Toufektchan, F. Toledo, 2020, Science Advances.

p53 downregulates the Fanconi anaemia DNA repair pathway

Eléonore Toufektchan, F. Toledo, V. Lejour, 2016, Nature Communications.

Assessment of human nter and cter BRCA1 mutations using growth and localization assays in yeast

A. Nicolas, D. Stoppa-Lyonnet, V. Lejour, 2011, Human mutation.

Essential role for centromeric factors following p53 loss and oncogenic transformation

G. Almouzni, L. Attardi, Eléonore Toufektchan, 2017, Genes & development.

Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival

F. Toledo, I. Simeonova, V. Lejour, 2014, Oncogene.

Mutant mice lacking the p53 C-terminal domain model telomere syndromes.

J. Bourdon, F. Toledo, I. Simeonova, 2013, Cell reports.

Ribosome biogenesis dysfunction leads to p53-mediated apoptosis and goblet cell differentiation of mouse intestinal stem/progenitor cells

F. Toledo, V. Lejour, A. Stedman, 2015, Cell Death and Differentiation.

Of mice and men

F. Toledo, I. Simeonova, V. Lejour, 2013, Transcription.

A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities

F. Toledo, V. Lejour, Jeanne Rakotopare, 2023, bioRxiv.

Yeast cells reveal the misfolding and the cellular mislocalization of the human BRCA1 protein

A. Nicolas, V. Lejour, Graça Raposo-Benedetti, 2016, Journal of Cell Science.

Mutant mice lacking the p53 C-terminal domain model telomere syndromes.

J. Bourdon, F. Toledo, I. Simeonova, 2013, Cell reports.